InvestorsHub Logo
Followers 26
Posts 2610
Boards Moderated 2
Alias Born 10/24/2015

Re: None

Friday, 10/07/2022 2:23:19 PM

Friday, October 07, 2022 2:23:19 PM

Post# of 41
A virtual panel will take place on Thursday, Oct 13, at 12:30pm ET / 5:30pm UK and will be moderated by LifeSci Partners Managing Director, Neil Canavan. The panel will highlight neoantigens as valuable targets in immunotherapy, neoantigen discovery, selection, and prediction, and tumour-infiltrating lymphocyte therapies as a platform for mobilising neoantigen reactive T-cells

Day Range:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ACHL News